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Introduction
Enzymes can be divided into two groups: (a) enzymes
that perform catalysis without the use of cofactors;
and (b) enzymes that require one or more cofactors.
Examples of the ﬁrst group are hydrolases, which carry
out catalysis by employing the amino acids present in
the polypeptide chain. Cofactor-dependent enzymes
usually make use of nonprotein groups. These cofac-
tors may be inorganic in nature, e.g. Cu+ or Fe–S
clusters, but organic molecules are also employed, e.g.
NADP+ or pyridoxal phosphate. Enzymes may harbor
a combination of cofactors, such as mitochondrial
complex II (succinate dehydrogenase), which contains
heme, ﬂavin, and three Fe–S clusters. Cofactors are
often noncovalently linked, and dissociate from the
enzyme during catalysis and thereby act as coenzymes,
e.g. NADP+, coenzyme A, or ubiquinone. Alterna-
tively, the cofactor is noncovalently bound but dissoci-
ation from the enzyme is not required for catalysis. In
fact, avid binding ensures that the cofactor does not
dissociate easily, and this may only occur if the protein
is denatured. In contrast, some speciﬁc cofactors, e.g.
lipoic acid and biotin, are exclusively bound covalently
to the polypeptide chain. The covalent lipoyl–lysine
and biotinyl–lysine bonds function as swinging arms
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Many enzymes use one or more cofactors, such as biotin, heme, or ﬂavin.
These cofactors may be bound to the enzyme in a noncovalent or covalent
manner. Although most ﬂavoproteins contain a noncovalently bound ﬂavin
cofactor (FMN or FAD), a large number have these cofactors covalently
linked to the polypeptide chain. Most covalent ﬂavin–protein linkages
involve a single cofactor attachment via a histidyl, tyrosyl, cysteinyl or
threonyl linkage. However, some ﬂavoproteins contain a ﬂavin that is teth-
ered to two amino acids. In the last decade, many studies have focused on
elucidating the mechanism(s) of covalent ﬂavin incorporation (ﬂavinyla-
tion) and the possible role(s) of covalent protein–ﬂavin bonds. These
endeavors have revealed that covalent ﬂavinylation is a post-translational
and self-catalytic process. This review presents an overview of the known
types of covalent ﬂavin bonds and the proposed mechanisms and roles of
covalent ﬂavinylation.
Abbreviations
6-HDNO, 6-hydroxy-D-nicotine oxidase; BBE, berberine bridge enzyme; ChitO, chito-oligosaccharide oxidase; CholO, cholesterol oxidase
type II; DAAO, D-amino acid oxidase; GMC, glucose oxidase ⁄methanol oxidase ⁄ cholesterol oxidase; GOOX, gluco-oligosaccharide oxidase;
LaspO, L-aspartate oxidase; MAO, monoamine oxidase; MSOX, monomeric sarcosine oxidase; Na+-NQR, Na+-translocating NADH-quinone
reductase; P2Ox, pyranose 2-oxidase; PCMH, p-cresol methylhydroxylase; PuO, putrescine oxidase; TMADH, trimethylamine
dehydrogenase; VAO, vanillyl-alcohol oxidase.
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that shuttle intermediate compounds between the
active sites of the respective enzyme complexes [1]. In
some enzymes, amino acyl groups act as covalent
cofactors, e.g. in disulﬁde reductases [2], and in other
proteins, redox cofactors are formed in situ from
amino acyl groups [3], e.g. topaquinone in serum
amine oxidase, tryptophan tryptophylquinone in bacte-
rial methylamine dehydrogenase, and cysteine trypto-
phylquinone in bacterial quino-cytochrome amine
dehydrogenases. Topaquinone is made without an
external catalyst, whereas the formation of tryptophan
tryptophylquinone and cysteine tryptophylquinone
does require external enzymes [4,5].
Heme and ﬂavin cofactors are the only examples
that can be either covalently or noncovalently bound
to enzymes. Most ﬂavoproteins contain a tightly but
noncovalently bound ﬂavin. Nevertheless, it is esti-
mated that about 10% of all ﬂavoproteins contain a
covalently bound ﬂavin. Several types of covalent
ﬂavin–protein linkages that have been discovered are
described in detail in the next section.
Types and occurrence of covalent
flavin–protein bonds
The ﬁrst experimental data to suggest the existence of
covalent ﬂavoproteins were published in the 1950s
[6–8]. Veriﬁcation of this atypical ﬂavin binding mode
was obtained upon isolation of succinate dehydro-
genase [9–11]. The ﬂavin–protein bond was identiﬁed
as an 8a-N3-histidyl–FAD linkage [12]. The seven
known types of covalent ﬂavin binding are 8a-N3-hist-
idyl–FAD ⁄FMN, 8a-N1-histidyl–FAD ⁄FMN, 8a-O-ty-
rosyl–FAD, 8a-S-cysteinyl–FAD, 6-S-cysteinyl–FMN,
8a-N1-histidyl-6-S-cysteinyl–FAD ⁄FMN, and phos-
phoester-threonyl–FMN (Fig. 1). The most abundant
type of covalent ﬂavin attachment is the one in which
FAD is bound to a histidine (Table 1). Cysteinyl–FAD
and cysteinyl–FMN linkages are less widespread, and
the tyrosyl–FAD linkage has been found only in p-cre-
sol methylhydroxylase (PCMH) and its close relative
4-ethylphenol methylene hydroxylase [13].
Most of the above-mentioned covalent ﬂavin–pro-
tein binding types have been known for some time
[14]. However, a novel kind of covalent FAD linkage
was discovered recently on inspection of the crystal
structure of gluco-oligosaccharide oxidase (GOOX)
from the fungus Acremonium strictum [15]. For each
enzyme molecule, there is one FAD molecule that is
covalently tethered via two bonds: an 8a-N1-histidyl–
FAD linkage, and a 6-S-cysteinyl–FAD linkage. This
was the ﬁrst report of a bicovalent ﬂavoenzyme and,
soon after, it was established that several other cova-
lent ﬂavoenzymes also contain a ﬂavin bound in the
same manner. These include aclacinomycin oxidore-
ductase [16], berberine bridge enzyme (BBE) [17],
hexose oxidase [18], hexose glycopeptide oxidase dbv29
[19], D-tetrahydrocannabinolic acid synthase [20], can-
nabidiolic acid synthase [20], and chito-oligosaccharide
oxidase (ChitO) [21].
Another novel type of covalent ﬂavin binding has
been described for the NqrB and NqrC subunits of the
Na+-translocating NADH-quinone reductase (Na+-
NQR) from Vibrio alginolyticus. In this case, FMN is
covalently linked to a threonine residue via a phospho-
ester bond [22]. Consequently, it represents the only
covalent ﬂavin–protein bond that does not involve a
linkage via the isoalloxazine moiety of the ﬂavin.
Besides the covalently linked FMN cofactors, the Na+-
NQR complex (NqrABCDEF), which is an integral
membrane enzyme, also contains a noncovalently
bound FAD in subunit NqrF and riboﬂavin as cofactor
[23]. Thereby, it represents the ﬁrst reported enzyme to
utilize riboﬂavin as a cofactor. The observation that the
covalent FMN linkage in NqrC from V. cholerae does
not occur when the protein is expressed in Escherichi-
a coli suggests that a speciﬁc ancillary enzyme is needed
for covalent FMN incorporation [24]. As the biochemi-
cal data on this unusual type of covalent FMN binding
are scarce, the mechanism of covalent threonyl–FMN
linkage formation and the functional role of the
covalent FMN–protein linkage in NqrB-type and
NqrC-type ﬂavoproteins remain unknown.
Two of the largest ﬂavoprotein families are the
glucose oxidase ⁄methanol oxidase ⁄ cholesterol oxidase
(GMC) family and the vanillyl-alcohol oxidase (VAO)
family. Each family has its own distinct protein fold
for binding of FAD. The VAO family of ﬂavopro-
teins includes a relatively large number of covalent
ﬂavoproteins [25,26]. Inspection of the genome
database has revealed that, based on the presence of
a conserved histidine, roughly one out of four
VAO-type protein sequences represents a histidyl–
FAD-containing ﬂavoprotein. Additionally, members
of this family have been shown to accommodate four
types of covalent attachment (8a-N3-histidyl–FAD,
8a-N1-histidyl–FAD, 8a-O-tyrosyl–FAD, and 8a-N1-
histidyl-6-S-cysteinyl–FAD). This suggests a correla-
tion between protein fold and the ability to form a
covalent ﬂavin–protein linkage. Strikingly, although
the VAO-type covalent ﬂavoproteins share a similar
structural fold, the residue that covalently tethers the
FAD cofactor via the 8-methyl moiety is not
conserved. The 8a-N1-histidyl–FAD-containing homo-
logs form an FAD linkage via a histidine close to the
N-terminus, which is located in the FAD-binding
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Fig. 1. (A) All known types of covalent flavin–protein linkages. FMN is show in black, FAD in black and gray, and known linking amino acids
in green. Sites of covalent attachment are indicated by arrows. The numbering of some isoalloxazine atoms is indicated. (B) Types of cova-
lent flavin–protein linkages in some known covalent flavoprotein structures. FAD is shown as sticks (yellow) together with the linking amino
acid (green). As no threonyl–FMN-containing flavoprotein structure is known, only a peptidyl-linked threonyl–FMN is shown. The images
were generated with PYMOL [90].
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Table 1. Covalent flavoproteins and their modes of covalent FAD or FMN binding. The family to which each flavoprotein belongs to is indi-
cated according to the following codes and PFAM ordering: pyridine nucleotide-disulfide oxidoreductase (PF07992); TMD (trimethylamine
dehydrogenase domain), Oxidored_FMN (PF00724); VAO, FAD_binding_4 (PF01565); GMC, GMC_oxred_N (PF00732); succinate dehydroge-
nase, FAD_binding_2 (PF00890); AMO, Amino_oxidase (PF01593); MSOX, DAAO (PF01266); BDR (reductase FAD-binding domain of reduc-










8a-Histidyl-6-S-cysteinyl GOOX [15] N1 Fungus VAO 2AXR
ChitO [70] ? Fungus VAO –
BBE [17] N1 Plant VAO 3D2D
Hexose oxidase [18] N1 Plant VAO –
Aclacinomycin oxidoreductase [16] N1 Bacteria VAO 2IPI
D-Tetrahydrocannabinolic acid synthase [20] ? Plant VAO –
Cannabidiolic acid synthase [20] ? Plant VAO –
8a-Histidyl VAO [62] N3 Fungus VAO 1VAO
CholO [141] N1 Bacteria VAO 1I19
Alditol oxidase [142] N1 Bacteria VAO 2VFR
6-HDNO [45] N1 Bacteria VAO 2BVG
Cytokinin dehydrogenase [143] N1 Plant VAO 1W1O
Eugenol oxidase [144] N3 Bacteria VAO –
L-Gulono-c-lactone oxidase [145] N1 Animal VAO –
L-Gluconolactone oxidase [146] N3 Fungus VAO –
L-Galactonolactone oxidase [147] N1 Yeast VAO –
D-Arabinono-1,4-lactone oxidase [148] Yeast VAO –
Sorbitol oxidase [149] ? Bacteria VAO –
Xylitol oxidase [150] ? Bacteria VAO –
Nectarin V [151] ? Plant VAO –
Choline oxidase [152] N3 Bacteria GMC 2JBV
P2Ox [153] N3 Fungus GMC 2IGK
Pyranose dehydrogenase [154] ? Fungus GMC –
Succinate dehydrogenase [12] N3 All Succinate dehydrogenase 1NEK
Fumarate reductase [152] N3 Bacteria Succinate dehydrogenase 1QLB
Sarcosine dehydrogenase [152] N3 Animal DAAO –
Dimethylglycine dehydrogenase [152] N3 Animal DAAO –
Dimethylglycine oxidase [155] N3 Bacteria DAAO 1PJ5
c-N-methylaminobutyrate oxidase [156] ? Bacteria DAAO –
Thiamine oxidase [152] N1 Bacteria ? –
Cyclopiazonate oxidocyclase [152] N1 Fungus ? –
8a-O-Tyrosyl PCMH [157] – Bacteria VAO 1WVE
8a-S-Cysteinyl MAO A [158] – Animal AMO 2BXR
MAO B [159] – Animal AMO 1GOS
Amadoriase I [54] – Fungus DAAO 3DJD
MSOX [36] – Bacteria DAAO 2GB0
Pipecolate oxidase [36] – Animal DAAO –
N-methyltryptophan oxidase [36,160] – Bacteria DAAO 2UZZ
Sarcosine oxidase [161] – Plant DAAO –
NikD [162] – Bacteria DAAO 2OLN
Flavocytochrome c552 ⁄ c553 [163,164] – Bacteria Pyridine nucleotide-disulfide
oxidoreductase
1FCD
Unknown Plant allergens BG60a [55]
and Phl P 4a [165]
– Plant VAO –
Unknown Tetrahydrofuran monooxygenase
reductase component (ThmD) [64]
– Bacteria BDR –
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3408 FEBS Journal 276 (2009) 3405–3427 ª 2009 The Authors Journal compilation ª 2009 FEBS
domain (Fig. 1B). In contrast, the residues that form
the 8a-N3-histidyl–FAD and 8a-O-tyrosyl–FAD
linkages are located at two different positions in the
cap domain (Fig. 1B). The 8a-N1-histidyl–FAD
linkage type appears to be prevalent in VAO-type
covalent ﬂavoproteins (Table 1) and, in some cases, is
accompanied by a 6-S-cysteinyl–FAD linkage. In
addition to the GMC-type and VAO-type ﬂavopro-
tein folds, other folds have been shown to facilitate
covalent ﬂavin binding (Table 1).
There seems to be no relationship between a speciﬁc
covalent bond type and a class of organisms (Table 1).
8a-S-Cysteinyl-FAD and the most abundant type of
monocovalent ﬂavin binding, 8a-histidyl–FAD, are
found in all kingdoms of life. The rare covalent ﬂavin–
protein linkages, 6-S-cysteinyl–FMN, threonyl–FMN,
and 8a-O-tyrosyl-FAD, have so far only been found in
bacterial proteins. Also, the variety of substrates trans-
formed by the different ﬂavin-containing enzymes
shows that a covalent ﬂavin is not required to convert
a speciﬁc class of substrates. This is nicely exempliﬁed
by a number of cases where the same substrate can be
converted by a covalent ﬂavoenzyme as well as by a
noncovalent ﬂavoenzyme. This is the case for hexose
oxidase, which contains a bicovalent FAD cofactor
[18], and glucose oxidase, which contains noncovalent
FAD [27]. Both enzymes catalyze the oxidation of the
C1 hydroxyl moiety on glucose, yielding the corre-
sponding lactone as product. Similarly, cholesterol
oxidases with covalent FAD and noncovalent FAD
provide another case of structurally unrelated enzymes
catalyzing the same reaction (convergent evolution)
[28,29]. One exception seems to be membrane-bound
succinate dehydrogenase (and the closely related fuma-
rate reductase), which is found in both prokaryotes





Fig. 2. General mechanism for covalent
8a-histidyl–flavin, tyrosyl–flavin or cysteinyl–
flavin formation. B1–B3 represent active site
bases potentially involved in covalent flaviny-
lation, and L stands for the ligand amino
acid (histidine, tyrosine, or cysteine) that












8a-Histidyl-6-S-cysteinyl Dbv29 [19]a N1 Bacteria VAO –
8a-Histidyl Heterotetrameric sarcosine oxidase [166] N3 Bacteria DAAO 1X31
NADH dehydrogenase type II [167] N1 Archaea Pyridine nucleotide-disulfide
oxidoreductase
–
6-S-Cysteinyl TMADH [168] – Bacteria TMD 2TMD
Dimethylamine dehydrogenase [169] – Bacteria TMD –
Histamine dehydrogenase [170] – Bacteria TMD –
Phosphoester-threonyl NqrB [22] Bacteria NQR
NqrC [22] Bacteria NQR –
a Sequence homology with BBE suggests an 8a-histidyl-6-S-cysteinyl–FAD linkage.
D. P. H. M. Heuts et al. On the role and formation of covalently bound flavin cofactors
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binding in all cases. This indicates that, during evolu-
tion, there has been some beneﬁt in acquiring and
retaining this speciﬁc type of covalent FAD–protein
bond.
From the list of covalent ﬂavoproteins in Table 1, it
is clear that most of these enzymes are involved in oxi-
dative processes. In fact, it is striking that most cova-
lent ﬂavoproteins are oxidases, and only a few
reductases and dehydrogenases are known that contain
a covalent ﬂavin. This is probably because covalent
ﬂavinylation usually signiﬁcantly increases the redox
potential (see below), thereby limiting the type of
electron-accepting redox partners to high-potential
partners.
Formation of covalent flavin–protein
bonds
For enzymes containing covalent heme or biotin, the
covalent attachment is catalyzed by a holocytochrome
c-lyase and a biotin-holocarboxylase synthetase,
respectively [30,31]. For covalent ﬂavin incorporation,
no ancillary enzymes that aid in forming the covalent
cofactor–protein bond have been described so far,
although it is believed that such enzymes are needed
for the phosphoester-threonyl–FMN linkage (see
above). Despite the growing number of known cova-
lent ﬂavoproteins, no unique protein sequence motif
has been found that can predict whether a ﬂavopro-
tein will contain a covalently bound ﬂavin. Recent
studies on the mechanism of covalent ﬂavinylation
strongly suggest that it represents a post-translational
self-catalytic protein modiﬁcation. In fact, the chemis-
try underlying covalent ﬂavinylation (Fig. 2) has been
proposed by numerous investigators since the discov-
ery of covalent ﬂavoproteins in the 1950s. A full
mechanistic scheme was ﬁrst published by Walsh
[32,33], although Bullock & Jardetzkey [34] proposed
that the ﬂavin iminoquinone methide isomer (formed
in step 1 of Fig. 2) formed during the exchange of
the 8a-hydrogens with solvent deuterium at high tem-
perature in D2O. This intermediate is also involved in
the base-catalyzed formation of 8a-N-morpholino-
2¢,3¢,4¢,5¢-tetraisobutrylriboﬂavin and 8a-N1-imidazol-
yl-2¢,3¢,4¢,5¢-tetraisobutrylriboﬂavin, and a dimer of
this ﬂavin linked via the 8a-carbons of each ﬂavin
unit [35]. The best-studied enzymes with regard to the
mechanism of covalent ﬂavinylation are monomeric
sarcosine oxidase (MSOX), PCMH, 6-hydroxy-d-nico-
tine oxidase (6-HDNO), VAO, and trimethylamine
dehydrogenase (TMADH). In the next paragraphs,
details on covalent ﬂavinylation of these ﬂavoenzymes
are presented.
MSOX
Bacterial monomeric MSOX catalyzes the oxidative
demethylation of sarcosine to yield glycine, formal-
dehyde, and hydrogen peroxide. MSOX contains one
covalent FAD per enzyme molecule, and the FAD is
linked via the 8a-methyl group of the isoalloxazine
moiety to Cys315 [36]. To study the covalent incorpo-
ration of FAD, an elegant method was applied in order
to obtain apo-MSOX: the enzyme was produced using a
riboﬂavin-dependent E. coli strain [37]. With this
approach, the apo-protein could be overexpressed and
puriﬁed. A time-dependent reduction of FAD under
anaerobic conditions was observed upon incubation of
apo-MSOX with FAD. The covalent coupling of FAD
to apo-MSOX resulted in an increase in catalytic acti-
vity. During the aerobic coupling reaction, stoichio-
metric amounts of hydrogen peroxide were produced,
implying the presence of a reduced ﬂavin intermediate
during covalent coupling, which is reoxidized by molec-
ular oxygen. These data suggest that covalent coupling
of FAD occurs in a self-catalytic manner. Further
evidence for the mechanism of covalent coupling was
obtained by conducting experiments where FAD
analogs were incubated with apo-MSOX. Covalent
FAD binding was not observed with the analogs
1-deaza-FAD and 5-deaza-FAD. This is explained by a
lower redox potential than that of free, unmodiﬁed
FAD, which could cause the decrease in acidity of the
C8-methyl protons of the FAD analogs (Fig. 2) through
decreased electrophilicity of the ﬂavin ring system [37].
PCMH
Bacterial PCMH catalyzes the oxidation of p-cresol to
4-hydroxybenzyl alcohol. The a2b2 tetramer consists of
two ﬂavoprotein subunits, each containing one cova-
lent FAD (PchF or a), and two c-type cytochrome
subunits (PchC or b), each containing one covalent
heme cofactor. For PCMH, the covalent 8a-O-tyrosyl–
FAD is also proposed to be formed self-catalytically
[38]. However, the covalent link does not form when
the apo a-subunit and FAD are incubated together.
Covalent binding occurs only when FAD is incubated
with PchF and PchC: FAD ﬁrst binds noncovalently
to the a-subunit, and when PchC binds to the holo
a-subunit, a conformational change is induced in the
latter that leads to covalent ﬂavinylation and further
structural changes [39]. When the 8a-O-tyrosyl–FAD
covalent bond forms, the isoalloxazine moiety of FAD
becomes reduced, which in turn, reduces the b-subunits,
as occurs during normal catalytic oxidation of the
substrate [38]. Interestingly, whereas 5-deaza-FAD
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does not bind covalently to MSOX, it does bind cova-
lently to PCMH [40].
6-HDNO
The second step in the bacterial degradation of nicotine
is catalyzed by 6-HDNO, which was one of the ﬁrst dis-
covered covalent ﬂavoproteins and has been extensively
studied [41–43]. By incubating the apo form of 6-HDNO
with [14C] FAD, it was shown that in vitro covalent
ﬂavinylation is a self-catalytic process [44]. Covalent
ﬂavinylation could be enhanced by the addition of
compounds such as glycerol 3-phosphate, glycerol, and
sucrose. Recently, the crystal structure of 6-HDNO was
solved, and this revealed that FAD is covalently bound
via an 8a-N1-histidyl linkage [45], not the previously
proposed 8a-N3-histidyl linkage [46].
VAO
For VAO, which oxidizes a range of phenolic com-
pounds, the covalent histidyl–FAD linkage is not
essential for folding, FAD binding, and activity. In
VAO, His422 covalently binds FAD. The H422A
mutant was expressed as a noncovalent ﬂavinylated
protein. Studies also revealed that covalent ﬂavinyla-
tion can occur after folding of the polypeptide chain:
the apo-proteins can tightly bind FAD upon its addi-
tion. This has also been shown for the VAO H61T
mutant, which lacks a covalently linked FAD but is
able to bind FAD tightly but noncovalently, and is
also able to perform catalysis. The apo and holo forms
of this VAO mutant display highly similar crystal
structures, indicating that, prior to self-catalytic cova-
lent ﬂavinylation, FAD binding occurs via a lock-
and-key mechanism [47]. Recently, the apo form of
wild-type VAO was produced and used for a study of
FAD binding [48]. It was shown that, as observed for
MSOX [37] and dimethylglycine dehydrogenase [49],
the apoprotein readily binds and covalently incorpo-
rates FAD by a relatively slow process (0.13 min)1 for
VAO) that involves reduction of the cofactor.
TMADH
Bacterial TMADH catalyzes the oxidative N-demethy-
lation of trimethylamine to yield dimethylamine and
formaldehyde. For TMADH, which contains 6-S-cys-
teinyl–FMN, a self-catalytic mechanism was proposed
in which the cysteinyl thiolate attacks the C6 of the
isoalloxazine moiety, after which the reduced covalent
complex is reoxidized by transfer of two electrons to
the enzyme’s Fe–S complex (Fig. 3) [50]. Alternatively,
the iminoquinone methide may also form as in Fig. 2,
and the cysteinyl–thiolate attacks its electrophilic
6-position to give covalently tethered reduced FMN.
For all the enzymes mentioned above, with the pos-
sible exception of TMADH, similar mechanisms for
covalent coupling of the ﬂavin at the C8a position
have been proposed (Fig. 2) [32,33,38,45,51,52]. Owing
to the increasing number of covalent ﬂavoprotein crys-
tal structures available, the proposed mechanisms of
covalent ﬂavinylation can be validated by comparing
active site residues that may be important for the
formation of these covalent bonds. The amino acids
that are involved in speciﬁc interactions with the ﬂavin
ring system and may facilitate formation of the cova-
lent protein–ﬂavin bond are indicated in Table 2 [51].
Fig. 3. Proposed mechanism for covalent
6-S-cysteinyl–FMN formation [50].
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The ﬁrst step of the proposed mechanisms for covalent
ﬂavinylation of the C8a position involves abstraction
of a proton from the C8 methyl group. It is possible
that the amino acyl residue that will covalently couple
to the ﬂavin fulﬁls this purpose, but, in any case, the
abstracted proton also needs to be removed from this
region of the protein. In the cases presented in
Table 2, there are potential bases near the residues that
tether the ﬂavin (4.2–5.6 A˚). Following deprotonation
of C8a, or in the case of a thiolate attack at the C6
position (Fig. 3), stabilization of the negative charge at
the N1–C2=O2 locus of the isoalloxazine moiety is
required. A positive charge near this locus can be sup-
plied by histidine, lysine (e.g. MSOX [51]), arginine
{e.g. PCMH [52] and VAO (Fraaije, unpublished
results)}, an internal positive electrostatic ﬁeld, or a
helix dipole (e.g. monoamine oxidase; Fig. 4). For
cytokinine dehydrogenase and GOOX, the nearest
amino acyl side chain is that of a tyrosine at 2.5 and
2.7 A˚, respectively. For 6-HDNO, an asparagine resi-
due is present at 3.3 A˚. In these cases, the nearest
amino acyl side chains are polar but uncharged. It
might be for these enzymes that the tyrosine and
asparagine serve as proton donors to stabilize the
negative charge on the N1 position or create an
effective microenvironment by amide backbones.
Following proton abstraction from the C8 methyl
group, the histidyl–imidazolyl, tyrosyl–phenolate or
Table 2. Distances between the covalent flavin factor and structural elements and amino acids putatively involved in covalent flavinylation. Pro-
tein Data Bank files used: CholO, 1I19; 6-HDNO, 2BVFA; GOOX, 1ZR6; VAO, 1VAO; alditol oxidase, 2VFR; aclacinomycin oxidase, 2IPI; cytokinin
dehydrogenase, 1W1Q; PCMH, 1WVE; succinate dehydrogenase, 1ZOY; MAO, 1O5W; TMADH, 2TMD; flavocytochrome c552/c553, 1FCD.
Protein N1–C2 = O2 locus (A˚) N5 (A˚) Flavin C8a or C6 atom (A˚) Protein ligand atom (A˚)
Alditol oxidase His372 O2 (2.8) Ser106 (3.0) Trp9 NE1–C8a (5.8) Trp9 NE1–His46 ND1 (4.8)
VAO Arg504 O2 Asp170 (3.4) His61 ND1–C8a (5.2) His61 ND1–His422 NE2 (4.4)
Choline oxidase His202 O2 (3.9) Pro188 amide (4.7) Trp80 NE1–C8a (4.8) Trp80 NE1–His131 ND1 (4.6)
Cytokinin dehydrogenase Tyr491 O2 (2.5) Asp169 (5.2) Tyr107 OH–C8a (5.7) Tyr107 OH–His105 ND1 (5.0)
Aclacinomycin oxidase His138 N1 (3.9) Cys130 amide (4.0) Gln132 OE1–C8a (6.0) Gln132 OE1–His70 ND1 (4.6)
Cys130 amide–C6 (4.4) Cys130 amide–Cys130 SG (3.0)
GOOX Tyr426 O2 (2.7) Thr129 (4.2) Tyr310 OH–C8a (5.8) Tyr310 OH–His70 ND1 (4.7)
Proton relay system Thr129 OG1–C6 (5.2) Thr129 OG1–Cys130 SG (3.8)
6-HDNO Asn413 O2 (3.3) His130 amide (4.6) Trp31 NE1–C8a (4.3) Trp31 NE1–His72 ND1 (4.2)
Proton relay system
PCMH Arg474 O2 (3.0) Glu380 (3.8) Asp440 OD1–C8a Asp440 OD1–Tyr384 OH (5.3)
MSOXb Lys348–O2 (2.8) Tyr254 (4.5) His45 ND1–C8a (6.5) His45 ND1–Cys315 SG (4.7)
Helix dipole Proton relay system
Flavocytochrome c552 ⁄ c553a Helix dipole Glu167 (4.8) Arg168 NH1–C8a (5.5) Arg168 NH1-Cys42 SG (5.1)
TMADHa Arg222 O2 (2.7) Cys30 amide (2.9) His29 ND1–C6 (4.8) His29 ND1–Cys30 SG (5.6)
Succinate dehydrogenase Helix dipole Gln62 amide (3.4) His365 ND1–C8a (4.4) FMN phosphate–His57 ND1 (5.2)
FMN ribityl O2–His NE1 (5.2)
MAO Ab Helix dipole Tyr444 (7.2) Trp397 NE1–C8a (3.6) Arg51 NH1–Cys406 SG (6.2)
Tyr407 (5.7)
a The data presented for these enzymes were abstracted from Trickey et al. [51]. b Complex with inhibitor covalent bound at the N5 position
of FAD.
Fig. 4. Close-up of the crystal structure of MAO B. The isoalloxa-
zine ring of FAD is in yellow. The axis of the pink helix points
directly at the C2-O of the isoalloxazine. Cys397, covalently bound
to the 8a-carbon of the isoalloxazine ring, is indicated by an arrow.
The image was generated with PYMOL [90] from the coordinates in
Protein Data Bank file 1OJ9.
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cysteinyl–thiolate attacks at the C8a, thereby forming
a covalent bond between the polypeptide chain and
the reduced ﬂavin.
Covalent ﬂavinylation via the C8a or C6 position
results in a negative charge at the N5 position on the
reduced isoalloxazine ring system. This may be subse-
quently protonated by a nearby amino acid side chain,
a proton relay system formed by water molecules, or
peptide backbone amides. The importance of a proton-
donating residue near N5 was demonstrated in the case
of replacing Asp170 in VAO. Most of the analyzed
Asp170 mutants suffered from incomplete FAD bind-
ing [53]. Finally, reoxidation of the reduced ﬂavin
occurs by transferring two electrons to oxygen, heme,
or an Fe–S cluster.
The bicovalently linked FAD cofactor provides a
new lead for investigating the covalent ﬂavinylation
mechanism. The proposed mechanisms for covalent
ﬂavinylation via the C8a or C6 position of the isoal-
loxazine ring system could also be valid for the forma-
tion of the bicovalent ﬂavin–protein bond. However, it
is difﬁcult to predict in which order these steps take
place, i.e. whether covalent ﬂavinylation occurs ﬁrst
via the C8a or the C6 position. The observation that
mutants of BBE, ChitO and GOOX with only one of
the two covalent linkages can be produced suggests
that formation of each covalent bond is independent
of each other.
Whereas the mechanistic features of covalent
ﬂavinylation have been largely elucidated, there is
little known about the degradation of ﬂavin–peptides.
This appears to be a relevant process, as ﬂavin–
peptides are associated with allergic reactions [54,55]
and heart disease-associated autoimmune responses
[56].
Roles of covalent flavinylation
For many years, the role of covalent ﬂavin binding
was not clear. However, in recent years, a number
of studies on individual enzymes have provided
insights into the function of covalent ﬂavin attach-
ment in several cases, as discussed below in more
detail.
Redox potential
That the redox potential of ﬂavins can be inﬂuenced
by chemical modiﬁcations or varying environments
(e.g. in a protein) has been known for some time. On
comparison of redox potentials that have been deter-
mined for noncovalent, monocovalent and bicovalent
ﬂavoproteins, a clear trend becomes apparent: covalent
coupling of a ﬂavin increases the midpoint potential
signiﬁcantly (Fig. 5). A similar effect has been
observed with chemically modiﬁed ﬂavins such as
8a-N-imidazolylriboﬂavin, which displays a midpoint
potential of )154 mV at pH 7.0, as compared to
)200 mV for free riboﬂavin [57]. The Em values for
other modiﬁed ﬂavins at pH 7.0 are as follows: 8a-N1-
histidylriboﬂavin, )160 mV; 8a-N3-histidylriboﬂavin,
)165 mV; 8a-O-tyrosylriboﬂavin, )169 mV; 8a-S-cys-
teinylriboﬂavin, )169 mV; and 6-S-cysteinylriboﬂavin,
)154 mV [58–60]. A detailed analysis of a large
Fig. 5. Redox potentials of noncovalently, monocovalently and bicovalently bound flavoproteins. The arrows indicate redox potentials of
flavoproteins in which one of the covalent bonds has been disrupted by site-directed mutagenesis (see Table 3). Noncovalent: )1 mV [91],
)21 mV [92], )23 mV [93], )26 mV [94], )58 mV [95], )65 mV [96], )77 mV [97], )79 mV [98], )85 mV [99], )90 mV [100], )92 mV [101],
)97 mV [102], )108 mV [103], )114 mV [104], )118 mV [105], )129 mV [106], )132 mV [107], )145 mV [98], )149 mV [108], )152 mV
[109], )159 mV [110], )170 mV, )255 mV, )172.5 mV, )245 mV [111], )190 mV [112], )200 mV [113], )205 mV [114], )207 mV (FAD),
)212 mV [115], )216 mV [116], )217 mV [28], )325 mV [117], )228 mV [118], )230 mV [119], )233 mV [120], )237 mV, )243 mV,
)227 mV [121], )251 mV [122], )255 mV [123], )268 mV [124], )271 mV [125], )277 mV [126], )277 mV [127], )280 mV [128], )290 mV
[129], )340 mV [130], )344 mV [131], )367 mV [132]. Monocovalent: +160 mV [133], +84 mV [63], +70 mV [134], +55 mV [62], +50 mV
[135], +40 mV [136], +8 mV [137], )2 mV [138], )3 mV [139], )50 mV [67], )101 mV [29], )109 mV [71], )105 mV [66]. Bicovalent:
+132 mV [68], +131 mV [70], +126 mV [140]. SHE, standard hydrogen electrode.
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number of ﬂavin analogs has revealed a Hammett rela-
tionship between the electron-donating or electron-
withdrawing properties of substituents at positions 7
and 8 on the isoalloxazine ring and the redox potential
of the respective ﬂavin [61]. Although the redox poten-
tial can be modulated by other ﬂavin–protein interac-
tions, it is clear that electron-withdrawing substituents
at position 8 increase the ﬂavin redox potential sub-
stantially [61]. The increase in redox potential would
allow an enzyme to oxidize the substrate more efﬁ-
ciently, although the redox potential change of the ﬂa-
vin alone will not necessarily give an accurate estimate
of relative activities; e.g. PCMH (+93 mV) versus
PchFC (+62 mV), where the former is more than 50
times more active (kcat value) then the latter [52] (see
below). Similarly, it has been observed that two
sequence-unrelated cholesterol oxidases from one bac-
terium, one with covalent FAD and the other with
noncovalent FAD, exhibit similar kcat values while
exhibiting signiﬁcantly different redox midpoint poten-
tials ()101 and )217 mV, respectively) [28,29]. Addi-
tionally, a higher redox potential results in a more
restricted selection of electron acceptors that can be
used, often leaving molecular oxygen as the only suit-
able electron acceptor. This may explain why most
covalent ﬂavoproteins exhibit oxidase activity, in con-
trast to noncovalent ﬂavoproteins which most often
are dehydrogenases ⁄ reductases. An exception is
PCMH, which uses a high-potential c-type heme
(+230 mV) as the electron acceptor [52].
The redox potentials of several covalently and non-
covalently bound ﬂavins in mutant forms of the
respective proteins have been determined (Table 3). In
all of these cases, the redox potential is drastically low-
ered upon removal of the covalent link between the
ﬂavin and the polypeptide chain. The ﬁrst systematic
study on the effect of covalent ﬂavinylation on the
redox potential, kinetic behavior and protein structural
integrity was performed with VAO [62], where FAD is
covalently attached via an 8a-N3-His422 linkage.
His422 was mutated to alanine, serine, and cysteine.
All altered forms of VAO contained tightly but non-
covalently bound FAD, and the crystal structure of
the H422A mutant is nearly identical to the structure
of wild-type VAO [62]. This indicates that covalent
binding does not involve drastic conformational
changes in the three-dimensional structure of the
enzyme, and that the covalent histidyl–FAD link is not
required to keep FAD bound to the enzyme. Redox
potential measurements of wild-type and H422A VAO
showed that the loss of the covalent linkage resulted in
a signiﬁcant decrease of the redox potential from
+55 mV for wild-type VAO to )65 mV for the
H422A mutant. In addition, for the H422A mutant,
the observed rate of reduction by substrate was one
order of magnitude lower than with wild-type VAO
(0.3 s)1 versus 3.3 s)1, respectively). Clearly, there is a
relationship between the redox potential and the oxida-
tive power of the enzyme, which is reﬂected in the
reduced observed rate of reduction [62]. This ﬁnding is
supported by studies on another VAO mutant. When
His61, which was expected to be involved in activating
His422 for covalent ﬂavinylation, was mutated to a
threonine, covalent binding of FAD no longer
occurred [47]. Instead, FAD was noncovalently bound,
and the crystal structure of the H61T mutant revealed
no major structural variations as compared with wild-
type VAO [47]. The mutation resulted in a similar
effect on the catalytic efﬁciency, a 10-fold decrease in
kcat, as was found for the H422A mutant. These data
clearly indicate that the covalent histidyl–FAD bond
induces an increase of the redox potential, which
enhances the oxidative power and facilitates efﬁcient
catalysis.
With PCMH, it was also shown that after the tyro-
sine normally covalently bound to FAD was mutated
to phenylalanine, the enzyme could still tightly bind
the ﬂavin noncovalently. Moreover, the mutant
Table 3. Redox potentials of covalent flavoproteins and their corresponding mutants containing noncovalently bound flavin.
Wild-type protein Midpoint potential (mV) Mutation Midpoint potential (mV) Reference
VAO +55 H422A –65 [62]
PCMH +84 Y384F +47 [52,63]
CholO –101 H69A –204 [29]
P2Ox –105 H167A –150 [66]
BBE +132 C166A +53 [68]
ChitO +131 C154A +70 [70]
H94A +164 [70]
GOOX +126 C130A +61 [140]
H70A  +69a [140]
a The redox potential of this mutant protein could not be accurately measured.
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enzyme could associate with the cytochrome c subunit,
forming the heterocomplex, although it displayed low-
ered activity. For PCMH, the rationale for covalent
ﬂavinylation also appears to have its origin in an
increased redox potential, and thereby the oxidative
power of the enzyme. The redox potential of wild-type
PCMH was +84–93 mV, whereas the noncovalent
FAD in the PCMH [PchF(Y384F)] mutant had a
redox potential of +34–48 mV [52,63]. This resulted in
a decrease in kcat from 121 to 3.8 s
)1. Also, for PchFC
(+62 mV) and PchFNC ()16 mV), kcat values were
2.2–4.4 s)1 and 0.08 s)1, respectively, again indicating
that the same enzyme with covalently bound ﬂavin is
more active than the counterpart with noncovalently
bound cofactor. It was suggested that the covalent
bond facilitates effective electron transfer from FAD
to the heme in the cytochrome c subunit; the electron
would tunnel to PchC using a pathway that involves
the 8a-carbon of FAD and the phenolic moiety of
Tyr384 [38]. This rationale could also apply to the
covalent FAD-containing and Fe–S cluster-containing
reductase ThmD from Pseudonocardia, in which the
ﬂavin is involved in an electron transfer process [64].
Unfortunately, the exact mode of covalent ﬂavin bind-
ing for this covalent ﬂavoprotein is still unknown. A
model structure of ThmD made using the crystal struc-
ture of benzoate dioxygenase reductase (Protein Data
Bank: 1KRH) as a template suggests that the C8a of
the ﬂavin points towards the nearby Fe–S cluster (Fra-
aije, unpublished results). A C8a-FAD–protein linkage
may be involved in covalently linking the cofactor, and
could facilitate electron transfer from the reductase to
the associated mono-oxygenase component. Intrigu-
ingly, the model indicates that there is no tyrosine,
histidine or cysteine close to the C8a-methyl group of
the ﬂavin.
Cholesterol oxidase type II (CholO, 8a-N1-histidyl–
FAD) from Brevibacterium sterolicum catalyzes the
oxidation of cholesterol and subsequent isomerization
into cholest-4-en-3-one. Upon mutation of the respec-
tive His69 into an alanine, CholO could no longer
covalently bind FAD, and this resulted in a drastic
decrease in redox potential [29]. For wild-type CholO,
a midpoint potential of )101 mV was determined,
whereas the mutant enzyme displayed a midpoint
potential of )204 mV [29]. A more recent study con-
ﬁrmed that the decrease in redox potential is responsi-
ble for a reduced rate of ﬂavin reduction, which
explains the 35-fold lowered catalytic activity [65]. The
crystal structure of the CholO His69 mutant also
revealed a distortion of the isoalloxazine ring moiety,
which may contribute to the signiﬁcant decrease in
redox potential.
For pyranose 2-oxidase (P2Ox) from Trametes multi-
color, removal of the histidine residue that covalently
binds FAD decreases the kcat by a factor of 5, and
lowers the reduction potential by 35 mV, as compared
with wild-type P2Ox [66]. A comparable effect on
redox potential and catalytic activity has been reported
for MSOX [67].
Following the recent elucidation of the crystal struc-
ture of the bicovalent ﬂavoprotein GOOX, several
other bicovalent ﬂavin-containing proteins were identi-
ﬁed. This novel covalent binding mode raises the ques-
tion of why a ﬂavoprotein would require bicovalent
attachment of a ﬂavin to the polypeptide chain. A pos-
sible reason for bicovalent FAD binding in BBE was
proposed. BBE from Eschscholzia californica, also
referred to as reticuline oxidase, is involved in benz-
ophenanthridine-type alkaloid biosynthesis in plants.
In BBE, FAD is covalently linked to the protein via
an 8a-histidyl and a 6-S-cysteinyl linkage [17]. The
wild-type BBE and the C166A mutant, the latter con-
taining FAD that is only covalently bound to His104,
were compared with regard to their kinetic properties
and redox potentials [68]. For wild-type BBE, a very
high redox potential of +132 mV was found, whereas
the C166A mutant exhibited a redox potential of
+53 mV. The difference in potential was directly
linked to the 360-fold decrease in the rate of ﬂavin
reduction by (S)-reticuline [68]. For BBE, it was con-
cluded that the 6-S-cysteinyl–FAD linkage is also
needed to increase the redox potential and thereby
enhance the catalytic efﬁciency. For the histidine
mutants of BBE, in which FAD is solely linked to
Cys166 (H104A and H104T), and the double mutant
H104T ⁄C166A, no data could be obtained, owing to
very low expression levels of the mutants [68]. The
recently elucidated crystal structure of BBE has
conﬁrmed the bicovalent linkage of the ﬂavin [69].
ChitO from Fusarium graminearum catalyzes the oxi-
dation of chito-oligosaccharides at the C1 hydroxyl
group to yield the corresponding lactones [21]. ChitO
was also shown to contain a bicovalently linked FAD.
In this fungal enzyme, the isoalloxazine moiety is teth-
ered to His94 and Cys154 [70]. The H94A and C154A
mutants were prepared, and their kinetic parameters
and redox potentials were measured. In both mutant
proteins, FAD was covalently attached to the remain-
ing linking residue. This indicates that either covalent
bond can be formed independently of the other, and
removing either covalent bond has a major effect on
activity. The observed reduction rates of FAD by
N-acetyl-d-glucosamine decreased by a factor of
approximately 700. For the C154A and wild-type
ChitO, similar results with respect to redox properties
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were obtained as compared with the C166A and wild-
type BBE. For the ChitO C154A mutant, a redox
potential of +70 mV was measured, whereas for
wild-type ChitO, a redox potential of +131 mV was
determined. In this case, it was again shown that the
covalent cysteinyl–FAD link is responsible for the
change in redox potential and could also explain the
lower rate of reduction. However, the C154A mutant
also exhibited a marked increase in Km for the sub-
strate N-acetyl-d-glucosamine, suggesting that removal
of this covalent bond also affects substrate binding.
This suggests a role for the cysteinyl–FAD linkage in
positioning FAD in a catalytically optimal conforma-
tion for substrate binding and ﬂavin reduction. This
idea is further supported by analysis of the H94A
mutant of ChitO. For this mutant, similar effects on
the kcat, the Km and observed rate of reduction were
found as for the C154A mutant. However, the redox
potential for the reductive half-reaction was found to
be even higher than that measured for the wild-type
enzyme: +164 mV. This extremely high redox poten-
tial clearly does not correlate with the decreased kcat
and lower rate of reduction, which suggests that both
covalent bonds of FAD to the polypeptide chain of
ChitO are required for correct positioning of the ﬂavin
to facilitate efﬁcient catalysis. The double anchoring of
FAD allows the protein to evolve a relatively open
active site that can bind bulky substrates. In this con-
text, it is striking to note that all recently reported
bicovalent ﬂavoprotein structures display remarkably
open active sites, and these enzymes act on relatively
bulky substrates (Fig. 6). In addition, ChitO may also
beneﬁt from the increased redox potential that is a
result of both covalent bonds. The double mutant
H94A ⁄C154A ChitO could not be analyzed, owing to
very low expression levels. For ChitO, the presence of
one covalent bond could be necessary for the establish-
ment of an increased redox potential, but the second
covalent linkage is required for ﬁxing FAD in the cata-
lytically correct conformation, allowing the formation
of a productive Michaelis complex [70].
In all of the cases described above, mainly histidyl–
FAD-containing enzymes, it appears that the func-
tional beneﬁt of acquiring and retaining a covalent
ﬂavin–protein link is to increase the redox potential
and thus also the oxidative power of the enzyme.
From these data, it is tempting to assume that if a rel-
atively high redox potential is beneﬁcial for catalysis,
ﬂavoenzymes typically form a histidyl–FAD linkage.
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Fig. 6. Surface representations of several covalent flavoenzyme structures and the corresponding substrates, illustrating the open active
sites of bicovalent flavoproteins. The protein structure images were generated with PYMOL [90].
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contains tyrosyl–FAD. A thorough analysis of
enzymes containing histidyl–FAD ⁄FMN and cyste-
inyl–FAD ⁄FMN and the respective noncovalent
mutants is essential to understand further the speciﬁc
role of the histidyl–ﬂavin linkage.
Structural integrity
Another reason for covalent ﬂavinylation could be to
enhance protein stability. For several ﬂavoenzymes,
removing the covalent bond leads to the production of
incorrectly folded apoenzyme. For alditol oxidase from
Streptomyces coelicolor, it was shown that upon muta-
tion of the respective histidine residue (His46), FAD
could no longer bind to the protein, and approximately
50% of the expressed protein was insoluble [71].
For recombinant human monoamine oxidase A
(MAO A), which contains covalent FAD (8a-S-cyste-
inyl), a mutant was prepared that no longer covalently
linked FAD (C406A), but the altered apo-MAO A
was still incorporated into the outer mitochondrial
membrane. The addition of FAD to C406A apo-
MAO A resulted in the FAD being bound tightly, but
noncovalently, and the activity was only 30% of that
measured with wild-type MAO A [72]. However, after
solubilization from the outer mitochondrial membrane,
the mutant enzyme was found to be unstable, in con-
trast to the wild-type MAO A, which is stable under
the same conditions. In this case, it appears that one
role of covalent ﬂavinylation is to stabilize the native
conformation of the protein structure [72].
Results from a recent study on a sequence-related
amine oxidase have hinted at another rationale for
covalent ﬂavinylation. The bacterial putrescine oxidase
(PuO) was shown to contain equal amounts of tightly
but noncovalently bound FAD and ADP [73]. On the
basis of the high degree of sequence identity between
mammalian MAO and PuO, only one dinucleotide
cofactor is expected to bind to PuO. MS analysis
revealed that PuO is isolated as a mixture of dimers
containing either two molecules of FAD, two mole-
cules of ADP, or one molecule of FAD and one mole-
cule of ADP. This indicates that ADP is competing
with FAD for binding. As ADP binding results in
inactive enzyme, such a competitive event may be the
driving force for creating a covalent FAD–protein
linkage, as observed in MAO, as this would ensure full
incorporation of FAD. To probe whether PuO could
be converted to a covalent ﬂavoprotein, an alanine res-
idue corresponding to the linking cysteine in human
MAO B was replaced by a cysteine. Intriguingly, the
A394C PuO mutant was indeed able to form a cova-
lent FAD–protein bond [73]. The ability to convert a
noncovalent ﬂavoprotein PuO into a covalent ﬂavo-
protein by a single amino acid replacement also con-
ﬁrms the self-catalytic nature of covalent ﬂavinylation.
A similar gene mutation event may have occurred
during the evolution of MAOs or other covalent ﬂavo-
proteins.
The effect of urea-induced unfolding was examined
for wild-type and H69A CholO. It was clearly shown
that unfolding of the mutant enzyme occurred at a
lower urea concentration than was needed to unfold
the wild-type enzyme. In addition, thermal denaturing
experiments revealed that the mutant enzyme exhibited
an approximately 10–15 C lower melting temperature
than wild-type CholO [74]. Thermal instability was
also observed for apo-6-HDNO. In this case, the
enzyme could be rescued upon incubation with FAD
and subsequent covalent ﬂavin linking [44].
For ChitO, substantial effects were observed on
mutating the amino acids involved in covalent ﬂaviny-
lation. As mentioned before, removal of one of the
covalent bonds affects the redox potential. However,
on the basis of changes in the Km value, it also appears
that loss of one covalent linkage prevents a stable,
functional Michaelis complex from forming. The muta-
tion also resulted in decreased structural stability, as,
for the H94A mutant, protein aggregation was
observed during redox potential measurements [70].
In the case of heterotetrameric sarcosine oxidase, it
was shown that the b-subunit, which contains covalent
histidyl–FMN, is catalytically inactive and forms labile
heterotetrameric complexes when it cannot covalently
bind FMN [75]. This indicates that the covalent link
between FMN and the respective histidine is required
for structural reasons, e.g. to form a stable heterotetra-
meric complex, and possibly to prevent cofactor loss.
Also for MSOX, it has been found that disruption of
the covalent FAD–protein bond prevents effective
binding of the oxidized ﬂavin [67].
In contrast, when His44 (to which FAD is normally
bound covalently) of fumarate reductase from E. coli
is changed to serine, cysteine or tyrosine, the complex
heterotetrameric protein, which also contains three
Fe–S clusters, assembles properly in the membrane of
the bacterium, and FAD is tightly bound noncovalent-
ly [76]. All mutant forms of the enzyme show activity,
albeit reduced, as compared with the wild-type
enzyme. Also, FAD can be removed and reincorpo-
rated without loss of activity of the H44C, H44Y and
H44R mutant forms of fumarate reductase. Hence,
covalent binding of FAD to the polypeptide has little
effect on structural integrity. In addition, Complex II
of Saccharomyces cerevisiae assembles properly in the
mitochondrial membrane when His90 (the residue
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covalently linked to FAD in the normal complex) is
mutated. For normal Complex II, FAD becomes cova-
lently bound in the mitochondrial matrix after the
signal peptide is cleaved.
For PCMH from Pseudomonas putida, the ﬂavo-
protein subunit can be expressed in E. coli, and as its
cytochrome subunit is not present, FAD is bound non-
covalently to the isolated protein. The ﬂavin is easily
removed from this ‘holo’ enzyme, and the stable apo-
protein can noncovalently rebind FAD. Exposure of
this ‘holo’ subunit to its partner cytochrome subunit
results in fully formed and fully active native ﬂavocy-
tochrome that has covalently bound FAD. A compari-
son of structure of the ﬂavoprotein harboring
covalently bound FAD [39] with the structures of the
ﬂavoprotein with noncovalently bound FAD or the
apo-ﬂavoprotein (F.S. Mathews & W.S. McIntire,
unpublished) indicates that the ﬂavin, whether cova-
lently bound or not, or missing, does not affect the
structural integrity of this protein.
A similar robustness of the apo form of a covalent
ﬂavoprotein has been observed for VAO. The crystal
structures of H61T apo-VAO, ADP-complexed H61T
VAO, and H61T holo-VAO and H422A holo-VAO,
both containing noncovalently bound FAD, revealed
that binding of FAD and formation of the covalent
FAD–protein bond do not cause any signiﬁcant struc-
tural changes [47,62]. Furthermore, it was recently
shown that wild-type VAO can be produced and
folded into a competent form to bind FAD in the
absence of any FAD [48]. These results indicate that
the apo forms of VAO and PCMH are able to fold
into a stable protein structure that is preorganized to
bind FAD and catalyze formation of the covalent
FAD–protein linkage in a post-translational process.
Flavin reactivity
A third reason for covalent ﬂavinylation has been sug-
gested for TMADH, which oxidizes trimethylamine to
form dimethylamine and formaldehyde [77]. TMADH
contains FMN that is covalently linked to a cysteine
via the C6 position of the ﬂavin isoalloxazine moiety.
Removal of the covalent bond by mutating the Cys30
to an alanyl resulted in the formation of 6-hydroxy-
FMN upon incubation with substrate [78]. The
6-hydroxy moiety that is formed after oxidation of the
substrate-reduced mutant, results from the reaction of
reduced FMN with molecular oxygen. It was suggested
that the covalent 6-S-cysteinyl–FMN has evolved to
prevent wild-type TMADH from forming the
6-hydroxy-FMN species, which renders the enzyme
inactive [79].
Enhanced lifetime of the holo-enzyme
Although no germane studies are available, some
enzymes may have evolved with covalently bound ﬂav-
ins to increase the in vivo lifetime of the protein. For
an enzyme with noncovalently bound ﬂavin, if ﬂavin
binding is not that tight or binding weakens as the pro-
tein ages, the ﬂavin may dissociate. In general,
apo-ﬂavoproteins are less stable than the holo forms
[80,81]. Furthermore, in cases where ﬂavin reassociation
is difﬁcult or impossible, the enzyme may be rendered
incompetent. This may be particularly important for
membrane-bound and extracellular ﬂavoenzymes,
which, once formed and inserted into the lipid bilayer or
excreted, would have limited access to free ﬂavin [76].
The examples above illustrate that, besides an effect
on redox potential, the covalent ﬂavin–protein bond
may also serve to, for example, increase the structural
stability of the protein and ⁄or ensure an optimal ﬂavin
conformation in the active site. This strongly suggests
that the role of covalent ﬂavinylation is enzyme-depen-
dent.
Artificial flavinylation
In the previous sections, current views on the mecha-
nism and function of covalent ﬂavinylation have been
discussed. The signiﬁcance of covalent ﬂavin binding
can also be examined by studying the effects of cova-
lent and noncovalent ﬂavinylation with ﬂavin analogs,
which have shown to be powerful active site probes
[82]. For several covalent and noncovalent ﬂavopro-
teins, ﬂavin analogs have been used to explore mecha-
nisms and effects of ﬂavin binding, and some examples
are presented and discussed below.
A study of covalent ﬂavinylation of the ﬂavoprotein
subunit (PchF) of PCMH was carried out using nine
FAD analogs (FAD*) [40,83,84]. Analogs with an
8-methyl group bound tightly but noncovalently to
apo-PchF [PchF(FAD*)NC] in the absence of the
cytochrome subunit (PchC), but bound covalently
when exposed to PchC; those analogs lacking 8-CH3
could not bind covalently. With PchC absent, the
redox potential of a covalently bound FAD* congener
was greater than it was when it was noncovalently
bound to PchF, and the potential increased further on
association of PchF(FAD*)C or PchF(FAD*)NC with
PchC, while maintaining covalent or noncovalent
FAD* binding. In other words, both covalent ﬂavin
attachment and a subunit association-induced confor-
mational change [39] caused increases in the redox
potential of bound FAD. As the potential increased
for over 30 forms of PchF and PCMH, the catalytic
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efﬁciency also increased. However, a better correlation
was uncovered when the potentials of the substrate
(ES) and FAD* (EF) in the enzyme–substrate complex
were taken into consideration; that is, Dln(kcat) is a
linear function of D(ES)EF) [63].
For PCMH, it was found that the logarithm of rate
constants for covalent ﬂavinylation was a linear func-
tion of the redox potential of FAD analogs noncova-
lently bound to PchF [40]. The correlation would
present itself if deprotonation of the 8-methyl group
(step 1, Fig. 2) were rate-limiting; the pKa (or rate of
deprotonation) of the 8-methyl proton should be a
function of the electron afﬁnity (i.e. redox potential) of
the isoalloxazine ring. Alternatively, the attack by the
nucleophilic amino acyl group on the vinylic 8-carbon
of the deprotonated ﬂavo-iminoquinonoid intermediate
(step 2, Fig. 2) may be the rate-limiting step. In this
case, the rate constant for this step would be a func-
tion of the redox potential of this tautomer, which is
assumed to be directly related to the potential of the
normal form of the ﬂavin.
The C406A mutant of MAO A, which lacks cova-
lently bound FAD, was studied by reconstituting the
apo mutant in vivo and in vitro with a large set of dif-
ferent FAD analogs. A clear effect was observed when
high redox potential FAD analogs were used for
reconstitution. To some extent, the ﬂavin analogs
could compensate for the decrease in redox potential
due to the disrupted FAD–protein linkage. Moreover,
lower redox potentials of FAD analogs as compared
with normal FAD caused the catalytic activity to drop
below the value that was determined for C406A holo-
MAO A [72].
With the CholO type II H69A mutant, which no
longer covalently binds FAD, an increase in redox
potential from )204 to )160 mV (as compared with
)101 mV for wild-type CholO) was observed upon
reconstitution with 8-chloro-FAD. At the same time,
this resulted in a 3.5-fold increase in activity, again
showing that the ﬂavin analog mimics the thermo-
dynamic effects resulting from covalent FAD binding
[29].
The examples above concern enzymes that naturally
contain a covalent ﬂavin and for which it has been
shown that the covalent bond is necessary to raise the
redox potential to a value that facilitates proper cataly-
sis. On the other hand, there are also examples of
proteins that normally do not contain a covalent
ﬂavin, but have been artiﬁcially covalently ﬂavinylated.
For example, the noncovalent ﬂavoproteins lipoamide
dehydrogenase, electron-transferring protein and lysine
N6-hydroxylase [85–87] slowly covalently incorporated
FAD when the respective apo-proteins are incubated
with 8-Cl-FAD (FAD is linked via an 8-carbon rather
than an 8a-carbon linkage). The covalent incorpora-
tion led to inactive enzymes, presumably because of a
perturbed positioning of the ﬂavin in the active site. In
addition, in the noncovalent ﬂavoprotein d-amino acid
oxidase (DAAO), the glycine at position 281 was
mutated to a cysteine. Isolated G281C apo-DAAO
was incubated with the thiol-reactive 8-methylsulfonyl-
FAD, which bound covalently to Cys281. This artiﬁ-
cial covalent ﬂavinylation (again, FAD is linked via an
8-carbon rather than 8a-carbon linkage) resulted in an
increased kcat value with d-alanine from 1.5 s
)1 for the
mutant enzyme, containing noncovalently bound
FAD, to 2.6 s)1 for the FAD–S-mutant enzyme [88].
This rate is 26% of the respective value for wild-type
DAAO. The covalent binding of the ﬂavin affected its
mobility, which was also reﬂected in the 13-fold
increased Km value as compared with wild-type DAAO
[88]. Another example is the artiﬁcial covalent ﬂaviny-
lation of l-aspartate oxidase (LaspO) [89]. LaspO is
involved in the biosynthesis of pyridine nucleotides in
E. coli. FAD in LaspO is noncovalently and relatively
weakly bound. To obtain an artiﬁcial covalent ﬂavo-
protein of LaspO, the apo-protein was incubated with
the ﬂavin analog N6-(6-carboxyhexyl)-FAD succinimi-
doester. The FAD analog was shown to be covalently
linked to Lys38, and this resulted in a mutant protein
that exhibited 2% of the activity that was found for
the wild-type enzyme. Although some activity was
measurable, it was clear that the microenvironment
around the isoalloxazine moiety of the FAD analog
cofactor was dramatically affected [89]. This shows
that even though, in many cases, covalent ﬂavinylation
appears to be advantageous to the enzyme, not just
any covalent bond between the ﬂavin and the poly-
peptide chain will yield an improved enzyme.
Concluding remarks
From the elucidation of several crystal structures and
many detailed analyses on covalent ﬂavin binding,
we are gradually obtaining more insights into the
mechanism and function of covalent ﬂavinylation.
The proposed mechanisms for covalent ﬂavinylation
are similar and supported by structural, spectral and
kinetic data. The recent ﬁnding of novel types of
covalent ﬂavin binding (FAD tethered via two amino
acyl residues and threonyl–FMN) shows that many
different covalent ﬂavin–protein interactions have
evolved, and that, some have probably not yet been
identiﬁed.
For many enzymes, several reasons for covalent
ﬂavinylation have been put forward and supported by
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experimental data. Covalent ﬂavinylation can increase
protein stability, ensure cofactor binding, and ⁄or
induce a relatively high redox potential of the cofactor.
Although the experimental data may show that a cova-
lent bond is there to increase the redox potential, dur-
ing the course of evolution this may have changed. It
could be that, originally, an enzyme experienced evolu-
tionary pressure to develop increased protein stability.
The enzyme subsequently acquired a covalent protein–
ﬂavin bond for this purpose. Before that, the redox
potential could have been optimized by some speciﬁc
active site residues. However, the acquisition of the
covalent ﬂavin results in an inherent increase in redox
potential, thereby relieving active site residues from the
evolutionary pressure of maintaining the correct redox
potential. During evolution, the respective active site
residues may have mutated, resulting in a lower redox
potential when the covalent bond is removed.
Probably, covalent ﬂavinylation has been intro-
duced in separate events in different ﬂavoproteins
during the course of evolution. This can be deduced
from the existence of diverse ﬂavin-binding folds in
covalent ﬂavoproteins, and also from the differences
within one type of binding fold. With regard to the
latter, in most VAO-type covalent ﬂavoproteins, the
ﬂavin is covalently linked to an amino acid that is
part of the FAD-binding domain, whereas in VAO,
the corresponding histidine is part of the substrate-
binding domain. In addition, for members of the
VAO family, the ﬂavin is most often linked via a
histidine, although a few have both a histidyl and a
cysteinyl linkage, and one, PCMH, has the tyrosyl–
FAD bond. Hence, over eons, this subclass of cova-
lent ﬂavoproteins has resorted to different strategies
to link the ﬂavin in order to gain an evolutionary
advantage. Taking these considerations together, it
can be concluded that, for the examined enzymes,
removal of the covalent bond has dramatic effects on
the ﬂavin redox potential and enzyme activity. Addi-
tionally, it has been established that covalent ﬂaviny-
lation seems to enhance protein stability and, in some
cases, can also affect Michaelis complex formation
and protein oligomerization.
For a richer understanding of the role of covalent
ﬂavin binding to proteins, the scope of the research
performed in this area should be broadened. Establish-
ing the effects of (removing) the covalent bond on
protein activity and other biochemical properties is
fundamentally different from assigning the role of
covalent ﬂavinylation on the basis of these effects.
Investigations aimed at assigning the importance of
covalent ﬂavin binding need to be linked to physiologi-
cal and phylogenetic data. Information on the physio-
logical fate of the enzyme, e.g. cellular localization and
the reaction that is catalyzed, as well as in-depth
knowledge of the evolution of this diverse class of
cofactor-containing proteins, could yield new insights
into the role of covalent ﬂavinylation.
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